6/94 virus, a parainfluenza type 1 virus recovered by lysolecithin fusion of multiple sclerosis brain cell cultures with CV-1 cells, replicated in monocyte macrophages and lymphocytes from normal human donors and from a patient with multiple sclerosis. In macrophage cultures, hemadsorption-positive cells and high levels of infectious virus became apparent within 24 to 48 h after infection, persisted for 6 days, and then began to decrease. Phytohemagglutinin-stimulated macrophages yielded similar titers of virus, but the levels were maintained for a longer period of time. Macrophage-produced virus appeared to be infectious for other macrophages in the same culture. Both unstimulated and phytohemagglutinin-stimulated lymphocytes also supported virus replication. Significantly higher titers were produced in the stimulated cultures, T cell-enriched populations producing more virus than unseparated populations whether stimulated or unstimulated. The presence or absence of antibodies to the virus in the donors did not appear to influence the levels of virus obtained in any of the leukocyte cultures. However, an increase in blastic forms after 6/94 virus infection was noted in lymphocytes from donors with antibodies as revealed morphologically and by increased incorporations of tritiated thymidine. Furthermore, 6/94 virusinfected lymphocytes, unlike Sendai virus-infected lymphocytes, were able to respond well to mitogenic stimulation by phytohemagglutinin.
Two preceding papers (22, 23) described studies on the interaction of mouse macrophages and lymphocytes with 6/94 virus, an agent recovered from brain cell-derived cultures from two patients with multiple sclerosis (MS) after lysolecithin-mediated fusion with CV-1 cells (20) .
The results of these studies indicated that the virus replicated in both macrophages and unstimulated lymphocytes.
Of interest was the finding that macrophages and lymphocytes derived from immunized mice that had high levels of specific humoral neutralizing antibodies were still variably susceptible to 6/94 infection. Zisman and Denman (26) reported that Sendai virus, an antigenic relative of the 6/94 agent (13) , was inactivated by human and mouse lymphocytes independent of the presence of humoral antibodies. Differences in infectivity between 6/94 and Sendai viruses for mouse macrophages (4, 22) and lymphocytes (23, 26) made it of interest to investigate the interaction of 6/94 virus with human leukocytes. Accordingly, this study of the interaction of 6/ 94 virus with cultures of cells from healthy do-nors with and without antibodies against 6/94 virus and with cultures of cells from an MS patient was undertaken.
MATERIALS AND METHODS Donors. Peripheral blood was obtained from six different subjects. Four of these donors were healthy members of the laboratory staff, aged 25 to 60 years, all of whom had circulating antibodies against 6/94 and Sendai viruses. One subject was a 24-year-old MS patient in the acute stage of the disease; he also possessed antibodies to 6/94 and Sendai viruses. Blood without antibodies against these viruses was obtained from a 5-year-old child who was bled for other purposes. Since infection with the HA2 strain of parainfluenza type 1 virus induces antibodies that cross-react to a high degree with 6/94 and Sendai strains, it is difficult to find 6/94 and Sendai virus antibody-free donors among older age groups (F. S. Lief, unpublished data).
Separation of leukocytes. Separation of leukocytes from erythrocytes (RBC) was made either by buffy coat prepared in Plasmagel (R. Bellon, Neuilly, Seine, France), or by sedimentation in a Ficoll-Hypaque gradient (1) . The leukocytes thus obtained were suspended at 5 x 10' to 10 x 106/ml in RPMI 1640 medium plus 10% fetal bovine serum and antibiotics as reported for mouse cells (22, 23) . The Table 1 shows the levels of neutralizing antibodies against both 6/94 and Sendai viruses in the blood of leukocyte donors. In each adult, the titer of antibody against 6/94 was similar to that of antibody against Sendai virus. The child lacked measurable antibodies to either virus.
RESULTS
Macrophages. Macrophages were obtained from three normal adults (designated NA-1, NA-2, and NA-4) and from one MS patient. The cultures were infected after 5 to 10 days of incubation in vitro, a time when the cells showed the best spreading and a typical morphology. The populations were 99% positive for phagocytosis of India ink or of sensitized sheep RBC and for acid-phosphatase activity.
Characteristics of infected macrophages. The responses of all the macrophage cultures to 6/94 virus infection were similar, regardless of the donors. Furthermore, cells derived from two or three repeated bleedings of the same adult donor also gave similar results. Most of the infected and uninfected cultures were observed for 3 to 4 days only. However, one set from a normal donor and two sets from the MS patient were kept for much longer periods of time, as bAssayed by the HAD-neutralization test, using 100 TCID50 of either virus.
VOL. 24, 1979 on October 26, 2017 by guest http://iai.asm.org/ Downloaded from described below. Initially, the infected cultures were indistinguishable from the uninfected controls either by morphology or by the presence of the typical macrophage markers. In the infected cultures, many HAD-positive cells became detectable after 24 h and their number increased over time. Interestingly, India ink phagocytosis and HAD were observed in the same cells. In the cultures maintained for more than 4 days, by 9 to 10 days most of the infected cells exhibited some cytopathic effect, showing rounding, although they remained spread with pale edges. This morphology was distinctly different from that of the control cells. Twenty days after infection, HAD was still detected in most of the cells. As the cultures grew older, they showed a decreased density, but the residual populations were still HAD positive. After 100 days, both infected and uninfected cultures showed marked degeneration, but in the infected cultures HADpositive cells were still observed.
Sensitivity to infection of human macrophages compared with other cells. Egggrown 6/94 virus gave the same HAD endpoint (usually 10-7 5) when titrated in human macrophages as when titrated in CV-1 cells. At 5 days after infection, the percentage of HAD-positive cells noted in both macrophage and CV-1 cell cultures decreased with the falling dilutions of virus. Only a few positive cells were detected in dilutions corresponding to the endpoint. However, when the same cultures were reincubated an additional 5 days, although the same endpoint of HAD was still detected, the CV-1 cells remained unchanged, whereas the macrophages showed a generalized cytopathic effect as described above. Nonetheless, in the macrophage cultures HAD became more extensive at the endpoint dilution, indicating that infectious virus must have been produced and transmitted to the remaining uninfected cells.
Production of infectious virus in unstimulated macrophages. When unstimulated macrophages were inoculated with 6/94 virus at a multiplicity of infection (MOI) of 2 to 4, they produced high levels of infectious virus within 24 to 48 h (Fig. 1) . The titers did not increase significantly for the next 6 days, but soon thereafter began to decrease. This decrease was apparently related to the decrease in the number of cells and to the changes of medium. At 25 days, not more than 1 log of infectious virus was still detectable (data not shown). At the peak of infectious virus production, the HA titers of supernatants were between 1:4 and 1:8, and the TCID5o was 104-0 to 104. Although the MS patient's cells produced about 0.5 log less virus at 6 days, and 2 logs less at 14 days, whether this finding can be considered significant is question- able.
Production of infectious virus in PHAstimulated macrophages. Dobrowolska and Kantoch (3) found that the increase in titers of poliovirus grown in mouse macrophages that were pretreated with PHA was related to macrophage replication. Therefore, to establish better conditions for viability and possibly to increase viral yield, cultures of human macrophages were exposed to 1% PHA for 3 days before infection. At that time, the treated cells showed an increase in size, some increase in number, and clumping. On inoculation of these stimulated cultures with 6/94 virus, it was found that after 7 days the amount of virus produced was the same as in unstimulated cells. However, in the stimulated cultures the viral titers were maintained at the same level for the next week, whereas the unstimulated cultures showed a 1-log decrease (Table 2) . At 25 days after infection, in both PHA-treated and untreated cultures, the numbers of cells remaining dropped and, consequently, so did the titers of infectious virus produced.
Lymphocytes. Figure 2 shows the titers of 6/94 virus found at different times after infection of lymphocytes from two normal adults, from the child, and from two different bleedings of the MS patient. It can be seen that when cells from the child and an adult (NA-4) were inoculated with an MOI of 10, they produced almost identical titers of virus. The cells from the second adult (NA-2) and both cultures from the MS patient inoculated with an MOI of 2 also yielded infectious virus, but the titers were somewhat lower than those produced at the higher MOI. Cells that were obtained from the other two adults (NA-1 and NA-3, not shown) and also inoculated at an MOI of 2 produced similar levels (3.5 to 3.75 logo EID5o [50% egg infective doses]). Maximal titers appeared quickly (1 to 3 days) and were sustained for 4 to 7 days.
Comparative titrations of lymphocyte-grown virus in eggs and CV-1 monolayers demonstrated that more virus was detectable by the former than by the latter system. However, slightly more virus infectious for CV-1 cells was produced after 7 days than after 1 day of incubation of lymphocytes (Table 4) .
Production ofinfectious virus in enriched populations of T and B lymphocytes. To try to establish the type of lymphocyte principally involved in the replication of 6/94 virus, lymphocyte populations from two normal adults (NA-1 and NA-2), enriched in T or B cells, were infected with an MOI of 4 ( Table 5 ). The titers of virus obtained from unseparated and enriched populations were about the same for both donors; therefore the average titers are given in Table 6 . It can be observed that at 24 h the titers of virus produced in the T-and B-enriched cultures appear not to be significantly different from those of unseparated cells. After 3 days of incubation, however, 1 log more of virus was produced by the T as compared to the B cells. It should also be noted that the titers produced approached those shown in Fig. 2 when unstimulated lymphocytes were infected at an MOI of 10.
Production of infectious virus in PHAstimulated lymphocytes. It is generally acknowledged that mitogenic stimulation of lymphocytes makes them more susceptible to viral infection (24) . Hence, unseparated lymphocytes from a normal adult (NA-2) as well as a Tenriched population from the same donor were stimulated with 0.5% PHA. After 3 days at 370C, stimulated and unstimulated cultures were in- 1, 6, 13) . ND, Not determined. Fig. 3 . It is apparent that between 1.5 and 2 logs more virus was produced in PHA-treated cells than in untreated cultures. Unfortunately, the unseparated and Tenriched populations could not be sampled on the same day. However, the figure suggests that on day 3, for example, the T-enriched populations produced slightly more virus than the unseparated populations. In addition, HAD and blast formation were much more extensive in PHA-stimulated lymphocytes than in unstimulated lymphocytes comprising either population ( Table 7) . Effect of 6/94 infection on blastogenesis induced by PHA. The inability of PHA to induce blastogenesis in lymphocytes infected in vitro or in vivo by viral agents has been reviewed by Wheelock et al. (24) . Since Sendai virus, which is antigenically related to 6/94 virus, has been found to be one of the strongest of such viral inhibitors (25) , it appeared important to test 6/94 virus with respect to this activity. Accordingly, lymphocytes from a normal adult (NA-2) were divided into three groups: (i) uninfected control; (ii) infected with 6/94 virus at an MOI of 10; and (iii) infected with Sendai virus at the same MOI. The cells of each group were then treated with 0.05% PHA either immediately (experiment 1), or 24 h after infection (experiment 2). The cultures were incubated at 320C for 3 days, and after an additional overnight incubation in the presence of [3H]thymidine, were processed for radioactivity determinations. After PHA treatment, the levels of incorporation rose significantly in the control of uninfected cultures and increased with time (Table 8) . In both experiments, the absolute values reached in control cultures were the same, although due to the higher basal value found in the unstimulated cultures of the second experiment, the stimulation ratios appeared to be different.
It became clear that Sendai virus depressed the incorporation of the labeled precursor in the unstimulated cultures of both experiments. PHA-treated Sendai-infected cultures showed about the same degree of incorporation as found in unstimulated, uninfected controls. These values were 91 to 97% lower than those detected in 1-. PHA-treated control cultures.
However, 6/94 did not depress incorporation of the labeled precursor in the unstimulated cultures of experiment 1, and only slightly depressed that in experiment 2. PHA treatment of 6/94 virus-infected cultures revealed a higher degree of incorporation than the unstimulated uninfected cells. However, these values were only one-third those obtained in PHA-stimulated control cultures.
DISCUSSION
It is apparent from our results that 6/94 virus is able to replicate in monocyte-macrophages and lymphocytes from both normal human donors and a patient with MS. It is of interest that the five adult donors had circulating neutralizing antibodies to the virus. The degree of replication in their cells was the same as found in the antibody-free child. The identity of the immunizing agent responsible for the 6/94 virus-reactive antibodies detected is not known. However, past exposure to other parainfluenza agents, especially type 1 (HA2 strain), could elicit such cross-reacting antibodies. Of interest also is that mice immunized intranasally with 6/94 virus and possessing much higher humoral antibody titers, which were known to be induced by 6/94 virus, (6, 18, 19, 21) . Isolation of other viruses from humans and animals possessing humoral antibodies has been reported (5, 7, 24) indicating that the persistence of intracellular virus is not necessarily incompatible with the presence of humoral immunity.
In human leukocyte cultures, 6/94 virus appeared very quickly and reached maximal titers faster than it did in macrophages or lymphocytes from either normal or immunized mice. However, direct comparisons are not possible because of the different origins of the cultures (blood for humans; peritoneum-spleen for mice) and because different kinetics of virus production have been observed in different types of mouse cells (22) .
As with mouse macrophages (22), 6 /94 virus infection of human macrophages did not destroy their phagocytic activity. However, along with the accelerated virus production, the human macrophage cultures showed a much earlier cytopathic effect (9 to 10 days, versus 30 to 40 days for mouse cultures). As the infected human cultures grew older, they revealed a decreased density, and after 100 days both the infected and control cultures became markedly degenerated. In the mouse cultures, on the other hand, the macrophages were gradually replaced by fibroblast-like cells that continued to exhibit a high degree of HAD and to secrete virus into the supernatant fluids, which indicates that infection was transmitted to the new cell population. Indeed, persistently infected cultures were thus established in macrophage cultures from three strains of mice (23) .
The (14, 16, 24) . The production of relatively high titers of 6/94 virus in unstimulated lymphocytes, however, is rather unexpected. Zisman and Denman (26) demonstrated that Sendai virus, which is antigenically related to 6/94 virus, was inactivated in both mouse and human lymphocyte cultures; a finding duplicated in our experiments with Sendai virus in mouse lymphocytes (23) . However, studies by Denman et al. (2) on the replication and inactivation of different viruses in human lymphocytes stressed the impossibility of predicting the outcome of viral infection on the basis of the structural features of the virus. The production of significant titers of infectious 6/94 virus in lymphocyte cultures indicates that, indeed, closely related viruses may behave very differently.
The titers of infectious virus produced seemed to be dependent on the initial input. Furthermore, under similar conditions no differences were observed in levels obtained in cultures from normal donors with or without antibodies, or from the MS patient.
An increase in blastic forms after 6/94 virus infection was noted in lymphocytes from adults with antibodies as revealed morphologically and demonstrated by the higher levels of tritiated thymidine incorporated into these cultures than in normal cells. However, this increase in blastic forms apparently did not modify the levels of infectious virus produced, since the titers were similar to those produced by the cultures derived from the child which barely showed an increased blastogenesis. More than likely, therefore, the blastogenesis observed in the adult cultures resulted from the stimulation of immunological memory from a previous contact with a related antigen, and not the acquisition of a permanent cellular immunity.
A particularly striking difference between 6/ 94 and Sendai virus is the low inhibition of the PHA blastogenic response exhibited by lymphocytes infected by the former virus in comparison with the strong inhibition observed in Sendai virus-infected cells. The ability to respond to mitogenic stimulation, as demonstrated in the 6/94-infected lymphocytes, and the enhancement of virus growth in stimulated lymphocytes would support the hypothesis that these cells, as well as macrophages, may also be involved in maintaining and carrying the infectious agent to distant parts of the body, although in this instance the role of 6/94 virus in producing disease is unknown. In addition, they could be the selec- normally is inactivated by lymphocytes.
As in mice, human T lymphocytes seem to support 6/94 virus growth better than B lymphocytes. However, experiments employing pure populations of each, rather than populations enriched in one type over the other, remain to be done.
